These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17196805)

  • 1. Synchronized and sustained release of multiple components in silymarin from erodible glyceryl monostearate matrix system.
    Lu C; Lu Y; Chen J; Zhang W; Wu W
    Eur J Pharm Biopharm; 2007 May; 66(2):210-9. PubMed ID: 17196805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronized and controlled release of multiple components in silymarin achieved by the osmotic release strategy.
    Xie Y; Lu Y; Qi J; Li X; Zhang X; Han J; Jin S; Yuan H; Wu W
    Int J Pharm; 2013 Jan; 441(1-2):111-20. PubMed ID: 23253304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability.
    Lian R; Lu Y; Qi J; Tan Y; Niu M; Guan P; Hu F; Wu W
    AAPS PharmSciTech; 2011 Dec; 12(4):1234-40. PubMed ID: 21948306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation of microemulsion systems for dermal delivery of silymarin.
    Panapisal V; Charoensri S; Tantituvanont A
    AAPS PharmSciTech; 2012 Jun; 13(2):389-99. PubMed ID: 22350738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and Characterization of Silymarin Synchronized and Sustained Release Dropping Pill.
    Liu ZH; Li XJ; Huang AW; Zhang J; Song HT
    Curr Drug Deliv; 2017; 14(5):650-657. PubMed ID: 28201965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in the flavonolignan composition of fruits from different Silybum marianum chemotypes and suspension cultures derived therefrom.
    Poppe L; Petersen M
    Phytochemistry; 2016 Nov; 131():68-75. PubMed ID: 27639292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and biopharmaceutical evaluation of supersaturatable self-nanoemulsifying drug delivery systems containing silymarin.
    Tung NT; Tran CS; Nguyen HA; Nguyen TD; Chi SC; Pham DV; Bui QD; Ho XH
    Int J Pharm; 2019 Jan; 555():63-76. PubMed ID: 30448315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and biopharmaceutical evaluation of silymarin using SMEDDS.
    Woo JS; Kim TS; Park JH; Chi SC
    Arch Pharm Res; 2007 Jan; 30(1):82-9. PubMed ID: 17328246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new silymarin preparation based on solid dispersion technique.
    Qiu MF; Jia W; Li SS; Xu ZH; Sun X; Wang XR; Zhang YY; Xie GX
    Adv Ther; 2005; 22(6):595-600. PubMed ID: 16510376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of silymarin synchronized-release microporous osmotic pump tablets.
    Zeng QP; Liu ZH; Huang AW; Zhang J; Song HT
    Drug Des Devel Ther; 2016; 10():519-31. PubMed ID: 26889080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery.
    Rawat MK; Jain A; Mishra A; Muthu MS; Singh S
    Ther Deliv; 2010 Jul; 1(1):63-73. PubMed ID: 22816120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies.
    Parveen R; Baboota S; Ali J; Ahuja A; Vasudev SS; Ahmad S
    Int J Pharm; 2011 Jul; 413(1-2):245-53. PubMed ID: 21549187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of two hydrophobic polymers on the release of gliclazide from their matrix tablets.
    Hussain T; Saeed T; Mumtaz AM; Javaid Z; Abbas K; Awais A; Idrees HA
    Acta Pol Pharm; 2013; 70(4):749-57. PubMed ID: 23923399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of silymarin and its flavonolignans on H(2)O(2)-induced oxidative stress in human keratinocytes and mouse fibroblasts.
    Svobodová A; Walterová D; Psotová J
    Burns; 2006 Dec; 32(8):973-9. PubMed ID: 17011711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier.
    Hussein A; El-Menshawe S; Afouna M
    Pharmazie; 2012 Mar; 67(3):209-14. PubMed ID: 22530301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release mechanisms of acetaminophen from polyethylene oxide/polyethylene glycol matrix tablets utilizing magnetic resonance imaging.
    Tajiri T; Morita S; Sakamoto R; Suzuki M; Yamanashi S; Ozaki Y; Kitamura S
    Int J Pharm; 2010 Aug; 395(1-2):147-53. PubMed ID: 20580795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of the dissolution rate of silymarin by means of solid dispersions.
    Li FQ; Hu JH
    Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):972-3. PubMed ID: 15304992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained and controlled release of herbal medicines: The concept of synchronized release.
    Chen Z; Zhu Q; Qi J; Lu Y; Wu W
    Int J Pharm; 2019 Apr; 560():116-125. PubMed ID: 30753930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: level A in vitro-in vivo correlation.
    Ochoa L; Igartua M; Hernández RM; Solinís MA; Gascón AR; Pedraz JL
    Eur J Pharm Biopharm; 2010 Jun; 75(2):232-7. PubMed ID: 20159037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silymarin extraction from milk thistle using hot water.
    Duan L; Carrier DJ; Clausen EC
    Appl Biochem Biotechnol; 2004; 113-116():559-68. PubMed ID: 15054277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.